Bottom line
How much do XLV and HRTS overlap?
57% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 69.8% of XLV's assets and 51.9% of HRTS's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings XLV and HRTS have in common
| Holding | % of XLV | % of HRTS | Overlap |
|---|---|---|---|
| Eli Lilly & Co | 16.51% | 11.52% | 11.52% |
| Johnson & Johnson | 10.64% | 3.59% | 3.59% |
| AbbVie Inc | 7.74% | 2.40% | 2.40% |
| UnitedHealth Group Inc | 6.57% | 5.24% | 5.24% |
| Merck & Co Inc | 5.52% | 4.27% | 4.27% |
| Amgen Inc | 3.40% | 1.91% | 1.91% |
| Thermo Fisher Scientific Inc | 3.24% | 3.97% | 3.24% |
| Abbott Laboratories | 2.75% | 2.61% | 2.61% |
| Gilead Sciences Inc | 2.73% | 3.43% | 2.73% |
| Vertex Pharmaceuticals Inc | 2.19% | 2.93% | 2.19% |
| Danaher Corp | 2.09% | 2.66% | 2.09% |
| Bristol-Myers Squibb Co | 2.05% | 2.09% | 2.05% |
| Medtronic PLC | 1.75% | 1.88% | 1.75% |
| McKesson Corp | 1.58% | 1.71% | 1.58% |
| Regeneron Pharmaceuticals Inc | 1.08% | 1.67% | 1.08% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in XLV
- Intuitive Surgical Inc — 2.45%
- Pfizer Inc — 2.39%
- CVS Health Corp — 2.30%
- Stryker Corp — 1.89%
- Elevance Health Inc — 1.46%
- Cigna Group/The — 1.27%
- Boston Scientific Corp — 1.10%
- HCA Healthcare Inc — 1.05%
- Cardinal Health Inc — 0.97%
- Cencora Inc — 0.96%
Only in HRTS
- Novo Nordisk A/S — 5.24%
- Roche Holding AG — 4.50%
- AstraZeneca PLC — 4.00%
- Novartis AG — 3.38%
- Revolution Medicines Inc — 3.33%
- Bridgebio Pharma Inc — 2.59%
- Cytokinetics Inc — 2.52%
- Teva Pharmaceutical Industries — 2.06%
- Dexcom Inc — 1.92%
- Edwards Lifesciences Corp — 1.75%
Asset mix
| Asset type | XLV | HRTS |
|---|---|---|
| Stocks | 99.7% | 99.2% |
| Cash & short-term funds | 0.3% | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Country mix
| Country | XLV | HRTS |
|---|---|---|
| US | 97.9% | 74.9% |
| CH | — | 7.9% |
| DK | — | 7.0% |
| GB | — | 4.0% |
| IE | 2.1% | 1.9% |
| IL | — | 2.1% |
| JP | — | 1.3% |
| CA | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / May 31, 2026)
Check another pair
FAQ
How much do XLV and HRTS overlap?
What stocks do XLV and HRTS have in common?
Should I own both XLV and HRTS?
Which holds more stocks, XLV or HRTS?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.